Research is investigating the role of common host genome variants in childhood acute lymphoblastic leukemia. Studies are exploring the impact of genetic polymorphisms on chemotherapy toxicity and treatment response in pediatric patients. The relationship between genetic variants and the development of leukemia, as well as potential long-term effects of chemotherapy, are also being examined.